“Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer.” by Nehme J, Maassen S, Bravaccini S, Zanoni M, Gianni C, De Giorgi U, Soto-Gamez A, Altulea A, Gheorghe T, Wang B, Demaria M has been just published in EMBO J. Congratulations to the authors!
PubMed ID: 39930269
